TRADE MARKS ACT 1995
DECISION OF A DELEGATE OF THE REGISTRAR OF TRADE MARKS WITH REASONS
Re:Opposition by AVENTIS PHARMA S.A. to registration of trade mark application 1243088(5) - RELTEC - filed in the name of MUNDIPHARMA AG.
Delegate: Bianca Irgang Representation: Opponent: Rebekah Gay of Shelston IP
Applicant: Did not attend the hearingDecision: 2010 ATMO 83
Section 52 opposition: section 44 pressed – s 44 ground of opposition not established since trade marks are not substantially identical or deceptively similar – evidence insufficient to establish any other grounds of opposition - Costs awarded against the opponent.Background
Mundipharma AG (‘the applicant’), filed application number 1243088 on 28 May 2008 in class 5 of the International Classification of Goods and Services (‘Nice’ classification). Details of the application are set out below.
Trade mark: RELTEC
Trade mark application: 1243088
Filing Date: 28 May 2008
Specification: Class 5: Pharmaceutical preparations for human use, in particular analgesics
The said application was accepted for possible registration and the official notice of acceptance was published in the Official Journal dated 8 January 2009. Subsequently Aventis Pharma S.A. (‘the opponent’) filed a Notice of Opposition (‘the Notice’) to the registration of the application on 27 February 2009. Thereafter the opponent served and filed evidence in accord with the provisions of the Trade Mark Regulations 1995 (‘the Regulations’).
I heard the matter in Sydney as a delegate of the Registrar of Trade Marks on 11 May 2010. The opponent was represented by Rebekah Gay of Shelston IP. The applicant did not attend the hearing or provide written submissions.
Grounds of Opposition
The Notice nominated most of the grounds of opposition available under the Act. The onus is upon the opponent to establish one or more of its grounds of opposition. Gyles J has referred to the standard of proof required in terms of a ‘balance of probabilities’.[1] His Honour’s findings upon that issue, arrived at after a consideration of the relevant authorities, have been discussed with approval by Sundberg J in Chocolaterie Guylian NV v Registrar of Trade Marks[2].
[1] Pfizer Products Inc v Karam [2006] FCA 1663; (2006) 70 IPR 599; (2006) AIPC 92-146
[2] [2009] FCA 891, (2009) AIPC 92-355; (2009) 82 IPR 13, para 22-27
At the hearing the opponent advised that it was not formally withdrawing any of the grounds of opposition listed in the Notice but that it would provide submissions only on section 44 of the Act. However, the opponent has not provided any evidence specific to prosecuting the grounds under the remaining grounds of opposition. Without more information than the opponent has provided in its evidence these grounds cannot be established.
Evidence
The evidence of the parties consists of the following declarations:
Declarant
Position
Date Made
Exhibits
Evidence in Support
Rebekah Frances Gay
Partner of Shelston IP Lawyers
26 November 2009
RFG-1
Opponent’s Evidence
The statutory declaration made by Ms Rebekah Frances Gay outlines that the opponent is the owner of trade mark registration…
Keep reading for free
Create a free CaseChat account to read Aventis Pharma S.A. v Mundipharma AG and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2010] ATMO 83
- Decision Date
CaseChat Overview and Summary
The primary legal issue before the Hearing Officer was whether the applicant's trade mark RELTEC was substantially identical with, or deceptively similar to, Mundipharma's registered trade mark RILUTEK, pursuant to section 44 of the relevant Act. To succeed in its opposition under section 44, Mundipharma was required to demonstrate the existence of a registered trade mark with an earlier priority date, covering similar goods or closely related services, and that the applicant's mark was substantially identical or deceptively similar to it.
The Hearing Officer reasoned that while both trade marks were coined words and commenced with the letter 'R', they were not substantially identical. Applying the "side-by-side" test, the Hearing Officer noted that RELTEC comprised six letters and RILUTEK comprised seven, and their spellings were distinct. These differences were considered sufficient to distinguish the marks from each other. As Mundipharma had not established the ground of opposition under section 44, and had not provided evidence to support its other grounds of opposition, the Hearing Officer decided to refuse the opposition. Consequently, the trade mark application was permitted to proceed to registration, subject to any appeal. Costs were awarded against Mundipharma.
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.